SCHEMBL8285256

SCHEMBL8285256

CC(C)(C)C(=O)N1CCN(c2cc3c(cn2)c(=O)cc(Nc2ccccc2)n3-c2ccccc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 1/20 0.44
SKP1 P63208 1/20 0.44
SKP2 Q13309 1/20 0.44
DCTPP1 Q9H773 1/20 0.41
SMO Q99835 1/20 0.41
PDE11A Q9HCR9 1/20 0.40
KMT2A Q03164 3/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
MAPT P10636 2/20 0.37
HTT P42858 2/20 0.37
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
P2RY12 Q9H244 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PDK2 Q15119 1/20 0.36
MAPK1 P28482 1/20 0.35
MEN1 O00255 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287220 0.90 CKS1B (0.41) CKS1BSKP1SKP2SMOPDE11A
SCHEMBL8285284 0.87 CKS1B (0.45) CKS1BSKP1SKP2PDE11AKMT2A
SCHEMBL8287232 0.87 MAPT (0.43) CKS1BSKP1SKP2PDE11ARAB9A
SCHEMBL8287497 0.86 PDE11A (0.46) PDE11AKMT2ANPC1RAB9AMAPT
SCHEMBL8287468 0.86 P2RY12 (0.41) PDE11AKMT2AMAPTHTTLMNA
SCHEMBL8287528 0.86 P2RY12 (0.44) SMOKMT2ANPC1RAB9AMAPT
SCHEMBL8361778 0.86 CDK4 (0.43) PDE11AALDH1A1FLT3GSK3B
SCHEMBL8286467 0.84 PDE11A (0.44) PDE11ANPC1MAPTHTTLMNA
SCHEMBL8287210 0.83 PDE11A (0.43) PDE11ANPC1RAB9AMAPTHTT
SCHEMBL8362922 0.83 ALDH1A1 (0.42) DCTPP1SMOPDE11AKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed